| Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands AG Dinmohamed, O Visser, RHA Verhoeven, MWJ Louwman, ... The Lancet Oncology 21 (6), 750-751, 2020 | 642 | 2020 |
| The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands AG Dinmohamed, M Cellamare, O Visser, L de Munck, MAG Elferink, ... Journal of hematology & oncology 13, 1-4, 2020 | 128 | 2020 |
| Two Plasmodium 6‐Cys family‐related proteins have distinct and critical roles in liver‐stage development T Annoura, BCL van Schaijk, IHJ Ploemen, M Sajid, J Lin, MW Vos, ... The FASEB Journal 28 (5), 2158-2170, 2014 | 104 | 2014 |
| Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012 AG Dinmohamed, O Visser, Y van Norden, NMA Blijlevens, ... Leukemia 30 (1), 24-31, 2016 | 84 | 2016 |
| Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010 AG Dinmohamed, O Visser, Y van Norden, PC Huijgens, P Sonneveld, ... European Journal of Cancer 50 (5), 1004-1012, 2014 | 84 | 2014 |
| Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015 M van der Meulen, AG Dinmohamed, O Visser, JK Doorduijn, ... Leukemia 31 (8), 1822-1825, 2017 | 58 | 2017 |
| Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival AG Dinmohamed, A Szabó, M Van Der Mark, O Visser, P Sonneveld, ... Leukemia 30 (2), 310-317, 2016 | 55 | 2016 |
| Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013 AG Dinmohamed, M Brink, O Visser, M Jongen-Lavrencic Leukemia 30 (6), 1449-1451, 2016 | 47 | 2016 |
| The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands AG Dinmohamed, Y van Norden, O Visser, EFM Posthuma, PC Huijgens, ... Leukemia research 39 (2), 177-182, 2015 | 47 | 2015 |
| Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality AMJ Reedijk, K Klein, JWW Coebergh, LC Kremer, AG Dinmohamed, ... Leukemia 33 (6), 1349-1359, 2019 | 42 | 2019 |
| Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry AG Dinmohamed, Y van Norden, O Visser, EFM Posthuma, PC Huijgens, ... Leukemia 29 (12), 2449-2451, 2015 | 42 | 2015 |
| Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands CGM Erkens, AG Dinmohamed, M Kamphorst, S Toumanian, ... The International Journal of Tuberculosis and Lung Disease 18 (4), 413-420, 2014 | 31 | 2014 |
| Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands AG Dinmohamed, EFM Posthuma, O Visser, AP Kater, RAP Raymakers, ... Blood, The Journal of the American Society of Hematology 131 (12), 1380-1383, 2018 | 27 | 2018 |
| Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities CAM Stege, B van der Holt, AG Dinmohamed, P Sonneveld, MD Levin, ... Leukemia 34 (7), 1964-1966, 2020 | 26 | 2020 |
| Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet—a population-based study AG Dinmohamed, O Visser Stem Cell Investigation 6, 2019 | 24 | 2019 |
| Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016 L van der Straten, MD Levin, O Visser, H Posthuma, J Doorduijn, A Kater, ... British journal of haematology, 2020 | 20 | 2020 |
| Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population IA van Zeventer, AO de Graaf, JB Salzbrunn, IM Nolte, P Kamphuis, ... Cancer Cell 41 (6), 1017-1031. e4, 2023 | 18 | 2023 |
| Primary therapy and relative survival in classical Hodgkin lymphoma: A nationwide population-based study in the Netherlands, 1989–2017 J Driessen, O Visser, JM Zijlstra, PJ Lugtenburg, WJ Plattel, MJ Kersten, ... Leukemia 35 (2), 494-505, 2021 | 18 | 2021 |
| Guideline-based indicators for adult patients with myelodysplastic syndromes K Stojkov, T Silzle, G Stussi, D Schwappach, J Bernhard, D Bowen, ... Blood advances 4 (16), 4029-4044, 2020 | 18 | 2020 |
| Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015 AMJ Reedijk, EAM Zijtregtop, JWW Coebergh, FAG Meyer‐Wentrup, ... British journal of haematology 189 (6), 1093-1106, 2020 | 18 | 2020 |
mark-david levinGeverifieerd e-mailadres voor asz.nl
